Cargando…
MS imaging of multicellular tumor spheroids and organoids as an emerging tool for personalized medicine and drug discovery
MS imaging (MSI) is a powerful tool in drug discovery because of its ability to interrogate a wide range of endogenous and exogenous molecules in a broad variety of samples. The impressive versatility of the approach, where almost any ionizable biomolecule can be analyzed, including peptides, protei...
Autores principales: | Wang, Yijia, Hummon, Amanda B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463860/ https://www.ncbi.nlm.nih.gov/pubmed/34461098 http://dx.doi.org/10.1016/j.jbc.2021.101139 |
Ejemplares similares
-
Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
por: Colella, Gianluca, et al.
Publicado: (2018) -
Development of Spheroid-FPOP:
An In-Cell Protein Footprinting
Method for 3D Tumor Spheroids
por: Shortt, Raquel L., et al.
Publicado: (2023) -
Impact of structural biologists and the Protein Data Bank on small-molecule drug discovery and development
por: Burley, Stephen K.
Publicado: (2021) -
Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine
por: Gilazieva, Zarema, et al.
Publicado: (2020) -
Live Multicellular Tumor Spheroid Models For High-Content Imaging
and Screening In Cancer Drug Discovery
por: Reid, Brian G., et al.
Publicado: (2014)